Clozapine and Sweet's syndrome: case report

A patient developed fever, raised inflammatory markers and a maculopapular rash following commencement of clozapine for treatment of his schizoaffective disorder. Skin biopsy confirmed Sweet's syndrome. Identification of the cause was challenging, with a number of possible considerations includ...

Full description

Bibliographic Details
Main Authors: Apphia Bunting, Daniel Silman, Minesh Karia, Sophie Johnson
Format: Article
Language:English
Published: Cambridge University Press 2023-09-01
Series:BJPsych Open
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S2056472423005136/type/journal_article
_version_ 1797693077752643584
author Apphia Bunting
Daniel Silman
Minesh Karia
Sophie Johnson
author_facet Apphia Bunting
Daniel Silman
Minesh Karia
Sophie Johnson
author_sort Apphia Bunting
collection DOAJ
description A patient developed fever, raised inflammatory markers and a maculopapular rash following commencement of clozapine for treatment of his schizoaffective disorder. Skin biopsy confirmed Sweet's syndrome. Identification of the cause was challenging, with a number of possible considerations including infection, malignancy and various potential drug triggers.
first_indexed 2024-03-12T02:38:22Z
format Article
id doaj.art-7d01d7021b7d48adba111cdffd6ee2b5
institution Directory Open Access Journal
issn 2056-4724
language English
last_indexed 2024-03-12T02:38:22Z
publishDate 2023-09-01
publisher Cambridge University Press
record_format Article
series BJPsych Open
spelling doaj.art-7d01d7021b7d48adba111cdffd6ee2b52023-09-04T10:51:17ZengCambridge University PressBJPsych Open2056-47242023-09-01910.1192/bjo.2023.513Clozapine and Sweet's syndrome: case reportApphia Bunting0https://orcid.org/0000-0001-6177-5158Daniel Silman1https://orcid.org/0000-0001-9069-6395Minesh Karia2Sophie Johnson3Oxford Health Foundation Trust, Warneford Hospital, Oxford, UKOxford Health NHS Foundation Trust, Oxford, UKOxford Health NHS Foundation Trust, Oxford, UKOxford Health NHS Foundation Trust, Oxford, UKA patient developed fever, raised inflammatory markers and a maculopapular rash following commencement of clozapine for treatment of his schizoaffective disorder. Skin biopsy confirmed Sweet's syndrome. Identification of the cause was challenging, with a number of possible considerations including infection, malignancy and various potential drug triggers.https://www.cambridge.org/core/product/identifier/S2056472423005136/type/journal_articleAntipsychoticsdrug or substance interactions and side-effectsin-patient treatmentschizophreniadermatology
spellingShingle Apphia Bunting
Daniel Silman
Minesh Karia
Sophie Johnson
Clozapine and Sweet's syndrome: case report
BJPsych Open
Antipsychotics
drug or substance interactions and side-effects
in-patient treatment
schizophrenia
dermatology
title Clozapine and Sweet's syndrome: case report
title_full Clozapine and Sweet's syndrome: case report
title_fullStr Clozapine and Sweet's syndrome: case report
title_full_unstemmed Clozapine and Sweet's syndrome: case report
title_short Clozapine and Sweet's syndrome: case report
title_sort clozapine and sweet s syndrome case report
topic Antipsychotics
drug or substance interactions and side-effects
in-patient treatment
schizophrenia
dermatology
url https://www.cambridge.org/core/product/identifier/S2056472423005136/type/journal_article
work_keys_str_mv AT apphiabunting clozapineandsweetssyndromecasereport
AT danielsilman clozapineandsweetssyndromecasereport
AT mineshkaria clozapineandsweetssyndromecasereport
AT sophiejohnson clozapineandsweetssyndromecasereport